222 related articles for article (PubMed ID: 25630969)
21. RARγ is a negative regulator of osteoclastogenesis.
Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
[TBL] [Abstract][Full Text] [Related]
22. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
Lopez TV; Lappin TR; Maxwell P; Shi Z; Lopez-Marure R; Aguilar C; Rocha-Zavaleta L
Int J Cancer; 2011 Dec; 129(11):2566-76. PubMed ID: 21442620
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy.
Lappin KM; Mills KI; Lappin TR
Stem Cells Transl Med; 2021 Jun; 10(6):836-843. PubMed ID: 33475252
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin couples hematopoiesis with bone formation.
Shiozawa Y; Jung Y; Ziegler AM; Pedersen EA; Wang J; Wang Z; Song J; Wang J; Lee CH; Sud S; Pienta KJ; Krebsbach PH; Taichman RS
PLoS One; 2010 May; 5(5):e10853. PubMed ID: 20523730
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin mediated bone formation is regulated by mTOR signaling.
Kim J; Jung Y; Sun H; Joseph J; Mishra A; Shiozawa Y; Wang J; Krebsbach PH; Taichman RS
J Cell Biochem; 2012 Jan; 113(1):220-8. PubMed ID: 21898543
[TBL] [Abstract][Full Text] [Related]
26. Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption.
Baud'huin M; Ruiz-Velasco C; Jego G; Charrier C; Gasiunas N; Gallagher J; Maillasson M; Naggi A; Padrines M; Redini F; Duplomb L; Heymann D
Eur J Cell Biol; 2011 Jan; 90(1):49-57. PubMed ID: 20970218
[TBL] [Abstract][Full Text] [Related]
27. Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio.
Rucci N; Rufo A; Alamanou M; Teti A
J Cell Biochem; 2007 Feb; 100(2):464-73. PubMed ID: 16927271
[TBL] [Abstract][Full Text] [Related]
28. Tyrosines 559 and 807 in the cytoplasmic tail of the macrophage colony-stimulating factor receptor play distinct roles in osteoclast differentiation and function.
Feng X; Takeshita S; Namba N; Wei S; Teitelbaum SL; Ross FP
Endocrinology; 2002 Dec; 143(12):4868-74. PubMed ID: 12446614
[TBL] [Abstract][Full Text] [Related]
29. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro.
Ming LG; Lv X; Ma XN; Ge BF; Zhen P; Song P; Zhou J; Ma HP; Xian CJ; Chen KM
Endocrinology; 2013 Mar; 154(3):1202-14. PubMed ID: 23389955
[TBL] [Abstract][Full Text] [Related]
30. The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice.
Awida Z; Bachar A; Saed H; Gorodov A; Ben-Califa N; Ibrahim M; Kolomansky A; Iden JA; Graniewitz Visacovsky L; Liron T; Hiram-Bab S; Brines M; Gabet Y; Neumann D
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008482
[TBL] [Abstract][Full Text] [Related]
31. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss.
Deshet-Unger N; Hiram-Bab S; Haim-Ohana Y; Mittelman M; Gabet Y; Neumann D
Sci Rep; 2016 Aug; 6():30998. PubMed ID: 27481313
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
[TBL] [Abstract][Full Text] [Related]
34. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
Kondo H; Takeuchi S; Togari A
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
[TBL] [Abstract][Full Text] [Related]
35. CD44 deficiency inhibits unloading-induced cortical bone loss through downregulation of osteoclast activity.
Li Y; Zhong G; Sun W; Zhao C; Zhang P; Song J; Zhao D; Jin X; Li Q; Ling S; Li Y
Sci Rep; 2015 Nov; 5():16124. PubMed ID: 26530337
[TBL] [Abstract][Full Text] [Related]
36. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
Thouverey C; Caverzasio J
Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
[TBL] [Abstract][Full Text] [Related]
37. The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.
Vinik Y; Shatz-Azoulay H; Vivanti A; Hever N; Levy Y; Karmona R; Brumfeld V; Baraghithy S; Attar-Lamdar M; Boura-Halfon S; Bab I; Zick Y
Elife; 2015 May; 4():e05914. PubMed ID: 25955862
[TBL] [Abstract][Full Text] [Related]
38. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
[TBL] [Abstract][Full Text] [Related]
39. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.
Huang S; Kaw M; Harris MT; Ebraheim N; McInerney MF; Najjar SM; Lecka-Czernik B
Bone; 2010 Apr; 46(4):1138-45. PubMed ID: 20044046
[TBL] [Abstract][Full Text] [Related]
40. A novel role for interferon regulatory factor 1 (IRF1) in regulation of bone metabolism.
Salem S; Gao C; Li A; Wang H; Nguyen-Yamamoto L; Goltzman D; Henderson JE; Gros P
J Cell Mol Med; 2014 Aug; 18(8):1588-98. PubMed ID: 24954358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
